Pmv Pharmaceuticals
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -34 | -33 | -32 | -32 |
EBITDA | -18,004 | -17,978 | -21,034 | -21,173 |
EBIT | -18,038 | -18,011 | -21,065 | -21,205 |
Net Income | -18,038 | -18,037 | -21,059 | -21,210 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -19,679 | -17,204 | -19,819 | -18,313 |
Cash | 39,130 | 37,983 | 36,337 | 44,127 |
Basic Shares | 53,331 | 53,280 | 52,993 | 52,010 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -133 | -1,144 | -1,257 | -650 |
EBITDA | -79,781 | -73,665 | -67,701 | -76,725 |
EBIT | -79,914 | -74,809 | -68,958 | -77,040 |
Net Income | -77,742 | -58,709 | -68,960 | -73,317 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -64,170 | |||
Free Cash Flow | -73,606 | -51,937 | -56,619 | -71,744 |
Cash | 37,983 | 40,876 | 37,706 | 108,297 |
Basic Shares | 52,541 | 51,578 | 48,014 | 45,594 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.34 |
2025-12-31 | -$0.34 |
2025-09-30 | -$0.40 |
2025-06-30 | -$0.41 |